Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I
We investigated the feasibility of utilizing an exon-skipping approach as a genotype-dependent therapeutic for neurofibromatosis type 1 (NF1) by determining which NF1 exons might be skipped while maintaining neurofibromin protein expression and GTPase activating protein (GAP)-related domain (GRD) fu...
Saved in:
Main Authors: | André Leier (Author), Marc Moore (Author), Hui Liu (Author), Michael Daniel (Author), Alexis M. Hyde (Author), Ludwine Messiaen (Author), Bruce R. Korf (Author), Jamuna Selvakumaran (Author), Lukasz Ciszewski (Author), Laura Lambert (Author), Jeremy Foote (Author), Margaret R. Wallace (Author), Robert A. Kesterson (Author), George Dickson (Author), Linda Popplewell (Author), Deeann Wallis (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
by: Jeroen Bremer, et al.
Published: (2019) -
Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014) -
Mutation-Directed Therapeutics for Neurofibromatosis Type I
by: Andre Leier, et al.
Published: (2020) -
Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model
by: Kelly M. Martinovich, et al.
Published: (2022) -
Targeted Exon Skipping to Address "Leaky" Mutations in the Dystrophin Gene
by: Sue Fletcher, et al.
Published: (2012)